Saturday, July 11, 2026

pharma · Crohn's Disease · Ulcerative Colitis (UC)

AbbVie

AbbVie is a pharma organization headquartered in Hamilton, CN. Primary therapeutic focus areas include Crohn's Disease, Ulcerative Colitis (UC), Psoriatic Arthritis, Rheumatoid Arthritis, Hidradenitis Suppurativa. NovaPh

1 Waukegan Road, North Chicago, Illinois 60064, US HQ
60,084 Employees
NMPA registrant Type
Company details
Status
Public
HQ
1 Waukegan Road, North Chicago, Illinois 60064, US
Employees
60,084
Programs
41
Drugs
32
Patents
25
Clinical program

methotrexate (MTX)

Approved · small molecule · Psoriatic Arthritis

methotrexate (MTX) for Psoriatic Arthritis is a Approved program (small_molecule) at AbbVie with 1 ClinicalTrials.gov record(s).

← All AbbVie projects Approved small molecule completed

Internal code M14-496

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
AbbVie
Phase
Approved
Modality
small_molecule
Indication
Psoriatic Arthritis
Status
completed
Trials
1